Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thermage snubs new acquisition offer; keeps to Reliant deal

This article was originally published in Clinica

Executive Summary

Thermage has rejected an alternative unsolicited acquisition proposal from an unnamed third party, and said it remains committed to its pending $95m merger with fellow skin repair specialist Reliant Technologies. Hayward, California-based Thermage had received the $5.50-per-share offer – payable either in cash or a cash-and-stock mix – from the interested party on August 20. However, the company said the Reliant deal will provide "significantly greater value" to Thermage stockholders. The Reliant/Thermage merger, announced in July (see Clinica No 1315, p 13), is expected to create a leader in the skin tissue repair market. The combined company is said to have generated revenue of $137m for fiscal 2008.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT041523

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel